JQ1 是三唑并二氮嗪化合物家族的一员，作为pan-BET（溴结构域和额外终端域）家族抑制剂发挥作用。已知 JQ1 可抑制细胞增殖，因此，可用作许多癌症的治疗药物，包括多发性骨髓瘤和急性髓性白血病。 JQ1 is a member of the triazolo-diazepine compound family, which functions as a pan-BET (bromodomain and extra-terminal motif) family inhibitor. JQ1 is known to suppress cell proliferation and therefore, can be used as a therapeutic drug for a number of cancers including multiple myeloma and acute myeloid leukemia. Product Application： (+)-JQ1 has been used in flow cytometry assay, cell viability assay and quantitative PCR assay in order to investigate on the reversal of HIV-1 latency.